Cytori Therapeutics moves European HQ from Switzerland to Deeside

Cytori Therapeutics, a San Diego-based [extra href=”#example” title=”Regenerative-Medicine is an emerging field, cell therapy seeks to repair or restore lost or damaged tissue function due to the effects of injury and disease” info=”tooltip” info_place=”top” info_trigger=”hover”] regenerative-medicine [/extra] company has consolidated its EU operations and moved to a new European office in Deeside which is combined with a manufacturing facility.

Cytori’s Deeside operation will house EU-based customer service and will be increasingly responsible for ongoing manufacturing of current and future products sold in the EU and other markets such as China.

The company received a number of incentives as part of the Welsh Government’s program to attract new business investment totalling £450,000 over several years and will go to supporting 30 jobs.

The news has been warmly welcomed by Welsh Economy Minister Edwina Hart, who said,

“I am delighted to welcome Cytori to Wales where they will establish their European headquarters. This is another significant boost for the life science sector in Wales and builds on the growing expertise within Wales in cell therapy and regenerative medicine.”

The official opening of the new facility will be on September 18th by Carwyn Jones, the First Minister of Wales.

Dr. Doug Arm, Cytori’s Sr. VP of Operations, said:

“We are delighted to have found an ideal location to set up our manufacturing HQ. We had initially considered establishing a smaller operation in the UK and had looked at a number of potential locations.

“However, support from the Welsh Government, the good engineering and life sciences skills base, the benefits of locating on Deeside Enterprise Zone and its good logistical connections and proximity to Manchester Airport were the key factors in our decision to consolidate our manufacturing operations to Wales.

“In addition, the growth of the sector in Wales, particularly the decision by ReNeuron to locate to Wales, encouraged us to make a more substantial investment for the primary manufacture of our systems, and over time expand our operations to other functional areas in Wales.”

Cytori has a particular focus on wound healing and is keen to further discussions with the Welsh Wound Innovation Centre about potential future collaborative opportunities in Wales.